Vaccine House India Profile
Key Indicators
- Authorised Capital ₹ 4.00 M
- Paid Up Capital ₹ 4.00 M
- Company Age 14 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 5.00 M
- Revenue Growth -43.52%
- Profit Growth 40.16%
- Ebitda 79.97%
- Net Worth 0.15%
- Total Assets -18.62%
About Vaccine House India
Vaccine House India Private Limited (VHIPL) is a Private Limited Indian Non-Government Company incorporated in India on 10 February 2010 and has a history of 14 years and 11 months. Its registered office is in Bhopal, Madhya Pradesh.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 4.00 M and a paid-up capital of Rs 4.00 M.
The company currently has active open charges totaling ₹5.00 M.
Company Details
-
LocationBhopal, Madhya Pradesh
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24232MP2010PTC023050
-
Company No.
023050
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
10 Feb 2010
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Gwalior
Industry
What products or services does Vaccine House India Private Limited offer?
Vaccine House India Private Limited offers a wide range of products and services, including Immunization & Vaccination Drugs, Infant Vaccines, Rabies Vaccine, Anti Infective Drugs & Medicines, Antiviral Drugs, Vaccines, Typhoid Vaccine, Tresivac Vaccine, Hepatitis A Vaccine, Rabipur Injection.
Who are the key members and board of directors at Vaccine House India?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Virendra Jain
|
Managing Director | 10-Feb-2010 | Current |
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
|
Payal Jain
|
Whole-Time Director | 10-Feb-2010 | Current |
|
Rajendra Jain
|
Director | 05-Jul-2019 | Current |
Financial Performance of Vaccine House India.
Vaccine House India Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 43.52% decrease. The company also saw a substantial improvement in profitability, with a 40.16% increase in profit. The company's net worth moved up by a moderate rise of 0.15%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Vaccine House India?
In 2020, Vaccine House India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Vaccicare Life Sciences Private LimitedVirendra Jain is a mutual person
-
Crispin Pharma Private Limited
Virendra Jain is a mutual person
-
J K Abode Private Limited
Virendra Jain is a mutual person
Charges (Loans)
₹5.00 M
₹0
Charges Breakdown by Lending Institutions
- Icici Bank Limited : 0.50 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 15 Dec 2010 | Icici Bank Limited | ₹5.00 M | Open |
How Many Employees Work at Vaccine House India?
Unlock and access historical data on people associated with Vaccine House India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Vaccine House India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Vaccine House India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
